EP. 1: Initial Strategies for Assessing and Treating mCRC
Experts in gastrointestinal oncology highlight their approaches to assessing patients with newly diagnosed metastatic colorectal cancer and explain the variables that factor into first-line treatment decisions.
EP. 2: Optimizing mCRC Treatment: Decision-Making With Patients
An overview of topics that oncologists should counsel patients on when working with them to select therapy to treat metastatic colon cancer.
EP. 6: Preferences for Second-Line Therapy for mCRC
Drs Cathy Eng and Joleen M. Hubbard explain how patients with metastatic colon cancer typically respond to initial treatment and describe the factors that impact second-line treatment decisions.
EP. 7: Second-Line Treatment of mCRC: Rechallenging Therapy
The role of molecular assays, including liquid biopsies, in providing information on resistance mechanisms in metastatic colorectal cancer and the impact of testing results on decisions for rechallenging with a previous therapy.
EP. 8: Treatments for BRAF-Mutated mCRC
Considerations for treating BRAF-mutated metastatic colorectal cancer with the combination of a BRAF inhibitor plus anti-EGFR agent based on recently presented data.
EP. 16: Best Practices Surrounding IO Treatment for mCRC
May 14th 2021Kanwal Raghav, MD, MBBS, of The University of Texas MD Anderson Cancer Center, discusses when it is most appropriate to initiate immunotherapy for metastatic colorectal cancer, highlighting the roles of tumor mutation burden and microsatellite instability as biomarkers for treatment.
EP. 21: Exciting Treatment Opportunities in mCRC
May 28th 2021Closing out a discussion on novel therapies used to individualize treatment for patients with metastatic colorectal cancer, a panel of gastrointestinal oncologists highlight the most exciting treatment opportunities being explored to address current gaps in care.